Editor's note: Every morning, James Altucher presents the most timely, topical posts from the Web's best business blogs.

Sirius

(SIRI) - Get Report

hits the

52-week low list

again.

A Dash of Insight gives

the complete lowdown

on

Transocean

(RIG) - Get Report

. Transocean was also covered in this weekend's

Barron's

article on

offshore drillers

.

Stockpickr's System trades of the day

include trades triggering this morning on

Taser International

(TASR)

and

JetBlue

(JBLU) - Get Report

.

Carl Icahn is on fire this year.

Motorola

( MOT) simply

should not fear him

.

If you're looking for the next

Dendreon

(DNDN)

, here are the biotech stocks with the

greatest short interest

, including

AtheroGenics

( AGIX) and

Coley

( COLY). They also all have a significant clinical event in the near future.

Seeking Alpha has

some interesting arbitrage ideas

: short

Amazon

(AMZN) - Get Report

, long

eBay

(EBAY) - Get Report

. And short

Yahoo!

(YHOO)

, long

Google

(GOOG) - Get Report

.

The best way to find stocks that are breaking out is to check out the

stocks that rose yesterday on unusual volume

.

Trader Mike asks :

Does Dow 13,000 mean everyone is richer

?

Portfolio.com wants to know whether

Google paid too much for Doubleclick

.

If Google seems high to you, just

forget about shorting it

.

Yes, it's true. Someone bought

this domain name

for $12.9 million, and it was worth it.

Buffetteer believes that Lasik surgery provider

LCA-Vision

(LCAV)

should get a lot more focus from investors

.

With the baby boom getting older, the demand for products and services from "death stocks" is practically guaranteed to increase.

Here are a few stocks that may prosper

from the aging of the American population.

Commodity Equity gives a lesson on why sugar is the next bull market and suggests

one stock to play it

.

Wow, the executives of

Schering-Plough

( SGP)

spend a lot of money

protecting themselves from PETA.

This is

the strangest YouTube story

that I've heard.

Here's an interesting collection of

stocks trading for more than $100

.

At the time of publication, Altucher and/or his fund had no positions in any of the stocks mentioned, although positions may change at any time.

James Altucher is a managing partner at Formula Capital, an alternative asset management firm that runs several quantitative-based hedge funds as well as a fund of hedge funds. He is also the author of

Trade Like a Hedge Fund

and

Trade Like Warren Buffett

. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Altucher appreciates your feedback;

click here

to send him an email.

TheStreet.com has a revenue-sharing relationship with Trader's Library under which it receives a portion of the revenue from purchases by customers directed there from TheStreet.com.